London
Roots Analysis has announced the addition of the “BiopharmaceuticalContract Biomanufacturing Market, (4th Edition), 2020-2030” reportto its list of offerings.
Giventhe rising popularity of biologics and the 8,000+ such product candidates underclinical investigation, the opportunity for contract manufacturing service providersengaged in this domain, is high and anticipated to persist in the mid-longterm, as well. In fact, since 2000, over 120 new CMOs have been established,offering a variety of cost-efficient manufacturing services and solutions to biologicdevelopers.
Toorder this 780+ page report, which features 300+ figures and 270+ tables,please visit this –
Key Market Insights
Presently,225 CMOs, possessing over 380 manufacturing facilities, claim to offermanufacturing services for biopharmaceutical products
The manufacturing services market for biopharmaceuticals ishighly fragmented, featuring a mix of small, mid-sized, large and very largeplayers. It is worth mentioning that more than 60% of CMOs mentioned in thereport, have the necessary capabilities to manufacture biologics across allscales of operation.
More than 65% of serviceproviders offer manufacturing services for recombinant proteins and peptides
Close to 58% of CMOs claim to have the requiredcapabilities to offer antibody manufacturing services. It is worth mentioningthat a number of biologics manufacturers are presently offering servicesrelated to the niche and emerging classes of biologics.
Over620 partnerships were established in this domain, during the period 2015-2020
Majority of the deals (~24%) recorded in the report, wereestablished in 2020, primarily driven by the investigational biologic drugsagainst COVID-19. Further, a large number (~35%) of the partnerships were observedto be focused on the manufacturing of biologics, followed by productdevelopment and manufacturing agreements (22%).
To request a customize report – https://www.rootsanalysis.com/reports/250/request-customization.html
Currently,the installed biopharmaceutical contract manufacturing capacity is estimated tobe ~3.9 million liters, which is gradually being expanded
In order to meet the growing demand for biologics, 177expansion projects were undertaken by CMOs between 2016 and 2020 Of theaforementioned initiatives, more than 40% were focused on the establishment ofnew facilities, followed by the expansion of existing manufacturing facilities(24%).
NorthAmerica and Europe are anticipated to capture 75% share (in terms of servicerevenues) of the market, by 2030
At present, close to 90% of the total revenues are generatedfrom projects involving commercialized biologic products, and this trend isunlikely to change significantly in the short to mid-term. Further, it is worthmentioning that the contract biomanufacturing market for biologics in the MiddleEast and North Africa is anticipated to grow at a relatively faster rate(13.6%), followed by the Asia-Pacific market (11.2%).
To request a sample copy / brochure of this report, please visitthis - https://www.rootsanalysis.com/reports/250/request-sample.html
KeyQuestions Answered
§ Who are the leadingplayers offering contract manufacturing services for biologics?
§ What percentage ofthe manufacturing operations for biopharmaceutical are presently outsourced?
§ What factors shouldbe taken into consideration while deciding whether the manufacturing operationsfor biologics should be kept in-house or outsourced?
§ What is the current,installed capacity for contract manufacturing for biopharmaceuticals?
§ What is the current,global demand for biologics and how is it likely to evolve in the foreseenfuture?
§ What are the key(geographical) manufacturing hubs for biologics?
§ What kind ofpartnership models are commonly adopted by stakeholders engaged in this domain?
§ What are thedifferent biopharmaceuticals focused initiatives undertaken by big pharmaplayers in the recent past?
§ How is the currentand future market opportunity likely to be distributed across key marketsegments?
The USD 34.2billion (by 2030) financial opportunity within the biopharmaceutical contractmanufacturing market has been analyzed across the following segments:
§ Commonlyoutsourced business operations
§ API
§ FDF
§ Typesof Expression Systems Used
§ Mammalian
§ Microbial
§ Others
§ Scaleof Operation
§ Preclinical/ Clinical
§ Commercial
§ CompanySize
§ Small
§ Mid-sized
§ Large/ Very Large
§ Typesof Biologics Manufactured
§ AntibodyTherapeutics
§ Vaccines
§ CellTherapies
§ OtherBiologics
§ KeyGeographical Regions
§ NorthAmerica
§ Europe
§ Asia-Pacific
§ LatinAmerica
§ MiddleEast and North Africa
The report includes profiles of key players (listedbelow) each profile features an overview of the company, information relatedto its biologics focused service portfolio, manufacturing facilities, recentdevelopments, and an informed future outlook.
§ AGC Biologics
§ Boehringer Ingelheim
§ Catalent
§ Cytiva (GEHealthcare)
§ FUJIFILM DiosynthBiotechnologies
§ KBI Biopharma
§ Kemwell Biopharma
§ Lonza
§ Luina Bio
§ Novasep
§ Olon
§ Patheon
§ Piramal PharmaSolutions
§ Takara Bio
§ WuXi AppTec (WuXiBiologics)
Foradditional details, please visit
https://www.rootsanalysis.com/reports/view_document/biopharmaceutical-contract-manufacturing-market/250.htmlemail sales@rootsanalysis.com
You may also beinterested in the following titles:
1. Vaccine Contract Manufacturing Market (3rdEdition), 2021-2030
2. ADC Contract Manufacturing Market (4thEdition), 2020-2030
3. Microbial Contract Manufacturing Market,2020-2030
4. Bispecific AntibodyTherapeutics Market
5. Antibody DrugConjugates (ADCs)
6. Alpha-1 AntitrypsinDeficiency (AATD)
About Roots Analysis
Roots Analysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
Contact Information
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
